Literature DB >> 2951567

Cellular composition of lymph in experimental lymphedema.

H Galkowska, W L Olszewski.   

Abstract

Lymph cell populations were characterized immunologically in dogs with chronic post-surgical lymphedema. There was a 10- to 30-fold increase in lymph total cell count as compared with normal (control) dogs. Morphologically, these were predominantly small lymphocytes with approximately 4-6% monocytes and veiled cells. In contrast, lymph from normal dogs contained 33% granulocytes and 27% monocytes. The Fc-R+ and C3b-R+ mononuclear nonadherent cells were less represented in lymph in chronic stasis than in normals. A high autotransformation rate of lymph cells and marked responsiveness to PHA and Con A were also observed. In chronic lymphedema K-cell and NK-cell cytotoxicity were lower than in normal lymph. Interruption or retardation of the lymphocyte recirculation pathway with lymph stasis may alter regulation of immune responsiveness in lymphedematous tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2951567

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  4 in total

1.  Sequential histopathology at the Rhipicephalus sanguineus tick feeding site on dogs and guinea pigs.

Authors:  M P Szabó; G H Bechara
Journal:  Exp Appl Acarol       Date:  1999-11       Impact factor: 2.132

2.  Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema.

Authors:  Tomer Avraham; Jamie C Zampell; Alan Yan; Sonia Elhadad; Evan S Weitman; Stanley G Rockson; Jacqueline Bromberg; Babak J Mehrara
Journal:  FASEB J       Date:  2012-11-27       Impact factor: 5.191

Review 3.  Inflammatory Manifestations of Lymphedema.

Authors:  Catherine L Ly; Raghu P Kataru; Babak J Mehrara
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

4.  CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis.

Authors:  Jamie C Zampell; Alan Yan; Sonia Elhadad; Tomer Avraham; Evan Weitman; Babak J Mehrara
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.